Companies / Dicerna Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
DRNACIK 1399529
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 28, 2021 | Koppel Adam Director | Other Shares tendered | Common Stock | $117.82M | -3.1M -100.00% | 0 | low |
| Dec 28, 2021 | Fambrough Douglas CEO | Other Sold to issuer | Common Stock | $8.85M | -231K -100.00% | 0 | low |
| Jul 6, 2021 | Weissman James B Executive | Sell Open-market sale | Common Stock | $1.17M | -30K -65.22% | 16,000 | medium |
| Jun 16, 2021 | Paglia Regina M. Executive | Sell Open-market sale | Common Stock | $1.12M | -31K -98.84% | 369 | medium |
| Feb 20, 2015 | Skyline Venture Partners V LP | Sell Open-market sale | Common Stock | $976.6K | -38K -2.14% | 1,719,671 | medium |
| Nov 18, 2021 | Brown Bob D Executive | Sell Open-market sale | Common Stock | $946.1K | -25K -98.94% | 267 | medium |
| Jun 14, 2021 | Ciappenelli Robert D. Executive | Sell Open-market sale | Common Stock | $760.0K | -20K -84.13% | 3,773 | medium |
| Dec 28, 2021 | Weissman James B Executive | Other Shares tendered | Common Stock | $692.3K | -18K -100.00% | 0 | low |